News blog

First embryonic stem cell trial approved outside the US

An embryonic field seems to be developing rapidly. Just two months after Advanced Cell Technology (ACT) launched the second and third trials involving products derived from human embryonic stem cells (ESCs) in an operating room at the University of California–Los Angeles, the Santa Monica-based biotech announced today that it had gained approval from the UK Medicines and Healthcare products Regulatory Agency to conduct the first ESC cell trial outside the US.

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE